Merlin, the neurofibromatosis type 2 gene product, and β1 integrin associate in isolated and differentiating Schwann cells

Journal of Neurobiology

Volumn 37, Issue 4, 1998, Pages 487-501

  Obremski, Valerie J ^b   Hall, Ashley M ^a   Fernandez Valle, Cristina ^a,b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b ORLANDO HEALTH   (United States)

Author keywords

1 integrin; Cancer; Neurofibromatosis type 2; Schwann cell myelination; Tissue culture; Tumor suppressor

Indexed keywords

INTEGRIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DRUG ISOLATION; NEURILEMOMA; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL;

ANIMALS; ANTIBODIES; ANTIGENS, CD29; CELL DIFFERENTIATION; CELLS, CULTURED; CROSS REACTIONS; CYTOSKELETAL PROTEINS; CYTOSKELETON; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MOLECULAR WEIGHT; MYELIN SHEATH; NEUROFIBROMATOSIS 2; NEUROFIBROMIN 2; NEURONS, AFFERENT; PRECIPITIN TESTS; RATS; RATS, SPRAGUE-DAWLEY; SCHWANN CELLS; SOLUBILITY;

EID: 0031738241     PISSN: 00223034     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4695(199812)37:4<487::AID-NEU1>3.0.CO;2-B     Document Type: Article

References (46)

1. ALGRAIN, M., TURUNEN, O., VAHERI, A., LOUVARD, D., and ARPIN, M. (1993). Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J. Cell Biol. 120:129-139.
2. DEN BAKKER, M. A., TASCILAR, M., RIEGMAN, P. H. J., HERMAN, R. A. C. P., BOERSMA, W., JANSSEN, P. J. A., DE JONG, T. A. W., HENDRICKS, W., VAN DER KWAST, T. H., and ZWARTHOFF, E. C. (1995). Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am. J. Pathol. 147:1339-1349.
3. BERRYMAN, M., GARYM, R., and BRETCHER, A. (1995). Ezrin oligomers are major cytoskeletal components of placental microvilli: a proposal for their involvement in cortical morphogenesis. J. Cell Biol. 131:1231-1242.
4. BIANCHI, A. B., HARA, T., RAMESH, V., GAO, J, KLEIN-SZANTO, A. J., MORIN, F., MENON, A.G., TROFATTER, J. A., GUSELLA, J. F., SEIZINGER, B. R., and KLEY, N. (1994). Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumor types. Nat. Genet. 6:185-192.
5. BOTTENSTEIN, J. E., and SATO, G. H. (1979). Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76:514-516.
6. BROCKES, J. P, FIELDS, K. L., and RAFF, M. C. (1979). Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 165:105-118.
7. BUNGE, M. B. (1993). Schwann cell regulation of extracellular matrix biosynthesis and assembly. In: Peripheral Neuropathy, 3rd ed. P. J. Dyck, P. K. Thomas, J. Griffin, and J. PODUSLO, EDS. PHILADELPHIA: SAUNDERS, PP. 299-316.
8. BUNGE, R., FERNANDEZ-VALLE, C. (1995). Basic biology of the Schwann cell. In: Neuroglia. H. Kettenmann and B. R. RANSOM, EDS. NEW YORK: OXFORD UNIVERSITY PRESS, PP. 44-57.
9. CLAUDIO, J. O., LUTCHMAN, M., and ROULEAU, G.A. (1995). Widespread but cell type-specific expressio of the mouse neurofibromatosis type 2 gene. Neuroreport 6:1942-1946.
10. EINHEBER, S., MILNER, T. A., GIANCOTTI, F., nd SALZER, J. L. (1993). Axonal regulation of SC integrin expression suggests a role for α6§4 in myelination. J. Cell Biol. 123: 1223-1236.
11. ELDRIDGE, C. F., BUNGE, M. B., and BUNGE, R.P. (1989). Differentiation of axon-related SCs in vitro: II. Control of myelin formation by basal lamina. J. Neurosci. 9:625-638.
12. ELDRIDGE, C. F., BUNGE, M. B., BUNGE, R. P., and WOOD, P. M. (1987). Differentiation of axon-related SCs in vitro: I. Ascorbic acid regulates basal lamina assembly and myelin formation. J. Cell Biol. 105:1023-1034.
13. EVANS, D. G. R., HUSON, S. M., DONNAI, D., NEARY, W., BLAIR, V., TEARE, D., NEWTON, V., STRACHAN, T., RAMSDEN, R., and HARRIS, R. (1992). A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness and confirmation of maternal transmission effect on severity. J. Med. Genet. 29:841-846.
14. FERNANDEZ-VALLE, C., FREGIEN, N., WOOD, P. M., and BUNGE, M. B. (1993). Expression of the protein zero myelin gene in axon-related Schwann cells is linked to basal lamina formation. Development 119:867-880.
15. FERNANDEZ-VALLE, C., GORMAN, D., GOMEZ, A. M., and BUNGE, M. B. (1997). Actin plays a role in both changes in cell shape and gene expression associated with Schwann cell myelination. J. Neurosci. 17:241-250.
16. FERNANDEZ-VALLE, C., GWYNN, L., WOOD, P. M, CARBONETTO, S., and BUNGE, M. B. (1994). Anti-β1 integrin antibody inhibits SC myelination. J. Neurobiol. 25:1207-1226.
17. FERNANDEZ-VALLE, C., WOOD, P. M., and BUNGE, M. B. (1998). Localization of focal adhesion kinase in differentiating Schwann cell/neuron cultures. Microsc. Res. Tech. 41:416-430.
18. GONZALEZ-AGOSTI, C., Xu, L., PINNEY, D., BEAUCHAMP, R., HOBBS, W., GUSELLA, J., and RAMESH, V. (1996). The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene 13:1239-1247.
19. GUENARD, V., GWYNN, L. A., and WOOD, P.M. (1995). Transforming growth factor-β blocks myelination but not ensheathment of axons by Schwann cells in vitro. J Neurosci. 15:419-428.
20. HAASE, V. H., TROFATTER, J. A., MACCOLLIN, M., TARTTELIN, E., GUSELLA, J. F., and RAMESH, V. (1994). The murine NF2 homologue encodes a highly conserved merlin protein with alternative forms. Hum. Mol. Genet. 3:407-411.
21. HARA, T., BIANCHI, A. B., SEIZINGER, B. R., and KLEY, N. (1994). Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene. Cancer Res. 54:330-335.
22. HITOTSUMATSU, T., KITAMOTO, T., IWAKI ,T., FUKUI, M., and TATEISHI, J. (1994). An exon 8-spliced out transcript of neurofibromatosis 2 gene is constitutively expressed in various human tissues. J Biochem . 116:1205-1207.
23. HORWITZ, A., DUGGAN, K., BUCK, C., BECKERLE, M. C., and BURRIDGE, K. (1986). Interaction of plasma membrane fibronectin receptor with talin: a transmembrane linkage. Nature 320:531-533.
24. HUYNH, D. P., NECHIPORUK, T., and PULST, S. M. (1994). Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene are conserved and code for schwannomins with distinct C-terminal domains. Hum. Mol. Genet. 3:1075-1079.
25. HUYNH, D. P., and PULST, S. M. (1996). Neurofibromatosis 2 antisense oligodeoxynucleotides induces reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene 13:73-84.
26. HUYNH, D. P., TRAN, T. M. D., NECHIPORUK, T., and PULST, S. M. (1996). Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development. Cell Growth Differ. 7:1551-1561.
27. KLEYAMANOVA, E. V., BIANCHI, A. A., KLEY, N., PYLEV, L. N., and WALKER, C. L. (1997). Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced meothelioma. Mol. Carcin. 18:54-60.
28. LUNA, E. J., and HITT, A. L. (1992). Cytoskeleton-plasma membrane interactions. Science 258:955-964.
29. LEE, J. H., SUNDARAM, V, STEIN, D. J., KINNEY, S. E., STACEY, D. W., and GOLUBIC, M. (1997). Reduced expression of schwannomin/merlin in human sporadic menigiomas. Neurosurgery 40:578-587.
30. MILNER, R., WILBY, M., NISHIMURA, S., BOYLEN, K., EDWARDS, G., FAWCETT. J., STREULI, C., PATELLA, R., FFRENCH CONSTANT, C. (1997). Division of labor of Schwann cell integrins during migration on peripheral nerve extracellular matrix ligands. Dev. Biol. 185:215-228.
31. MIYAMOTO, S., TERAMOTO, H., Coso, O. A., GUTKIND, J. S., BURBELO, P. D., AKIYAMA, S. K., and YAMADA, M. (1995). Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol. 131:791-805.
32. PLOPPER, G., and INGBER, D. E. (1993). Rapid induction and isolation of focal adhesion complexes. Biochem. Biophys. Res. Commun. 193:571-578.
33. PYKETT, M. J., MURPHY, M., HARNISH, P. R., and GEORGE, D. L. (1994). The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Hum. Mol. Genet. 3:559-564.
34. ROULEAU, G. A., MEREL, P., LUTCHMAN, M., SANSON, M., ZUCMAN, J., MARINEAU, C., HOANG-XUAN, K., DEMCZUK, S., DESMAZE, C., PLOUGASTEL, B., PULST, S. M., LENOIR, G., BIJLSMA, E., FASHOLD, R., DUMANSKI, J., DE JONG, P., PARRY, D., ELDRIDGE, R., AURIAS, A. DELATTRE, O., and THOMAS, G. (1993). Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363:515-521.
35. SATO, N., FUNAYAMA, N., NAGAFUCHI, A., YONEMURA, S., TSUKITA, S. A., and TSUKITA, S. H. (1992). A gene family consisting of ezrin, radixin and moesin: its specific localization at actin filament/plasma membrane association sites. J. Cell Sci. 103:131-143.
36. SCHALLER, M. D., OTEY, C. A., HILDEBRAND, J. D., and PARSONS, J. T. (1995). Focal adhesion kinase and paxillin bind to peptides mimicking ß1 integrin cytoplasmic domains. J. Cell Biol. 130:1181-1187.
37. SCHERER, S. S., and GUTMANN, D. H. (1996). Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J. Neurosci. Res. 46:595-605.
38. SCHMUCKER, B., BALLHAUSEN, W. G., and KRESSEL, M. (1997). Subcellular localization and expression pattern of of the neurofibromatosis type 2 protein merlin/schwannomin. Eur. J. Cell Biol. 72:46-53.
39. SCHWARTZ, M. A. SCHALLER, M. D., and GINSBERG, M. H. (1995). Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Biol. 11:549-599.
40. SCOLES, D. R., HUYNH, D. P., MORCOS, P. A., COULSELL, E. R., ROBINSON, N. G. G., TAMANOI, F., and PULST, S. M. (1998). Identification and characterization of interaction between the NF2 gene product schwannomin and βII-spectrin. Nat. Genet. 18:354-359.
41. SHAW, R. J., MCCLATCHEY, A. I., and JACKS, T. (1998). Regulation of the neurofibromatosis type 2 tumor suppresor protein, merlin, by adhesion and growth arrest stimuli. J. Biol. Chem. 273:7757-7764.
42. TAKESHIMA, H., IZAWA, I., LEE, P. S., SAFDAR, N., LEVIN, V. A., and SAYA, H. (1994). Detection of cellular proteins that ineract with the NF2 tumor suppressor gene product. Oncogene 9:2135-2144.
43. TROFATTER, J. A., MACCOLLIN, M. M., RUTTER, J. L., MURRELL, J. R., DUYAO, M. P., PARRY, D. M., ELDRIDGE, R., KLEY, N., MENON, A. G., PULASKI, K., HAASE, V. H., AMBROSE, C. M., MUNROE, D., BOVE, C., HAINES, J. L., MARTUZA, R. L., MACDONALD, M. E., SEIZINGER, B. R., SHORT, M. P., BUCKLER, A. J., and GUSELLA, J. F. (1993). A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791-800.
44. TSUKITA, S., OISHI, K., SATO, N., SAGARA, J., KAWAI, A., and TSUKITA, S. (1994). ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:391-401.
45. TURUNEN, O., WAHLSTROM, T., and VAHERI, A. (1994). Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J. Cell Biol. 126:1445-1453.
46. Xu, H. M., and GUTMANN, D. H. (1998) Merlin differentialy associates with the microtubule and actin cytoskeleton. J. Neurosci. Res. 51:403-415.